|Articles|October 13, 2020
Can a Two-Step Process Be an Effective Monoclonal Antibody Purification Platform?
Author(s)Tosoh Bioscience
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
What a $2 Billion Maryland Expansion Means for the Future of Biologics Production
2
Op-Ed: Why the US Must Move Beyond Its mRNA Monoculture
3
How New ADC Modalities Backed by Samsung Could Shape Solid Tumor Treatment
4
Industry Experts Probe CNPV Impacts: Part II
5
